Skip to main navigation
  • HOME
  • ABOUT ENZON
  • ROYALTY PRODUCTS
  • INVESTORS & MEDIA

    Investor Relations

    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Stock Quote
    • Stock Lookup
    • Contact Us
  • CONTACT US
  • Request Information
  • Email Alerts
  • Download Library
  • RSS News Feeds
Shareholder Tools
Downloads
Print

Downloads

Oct 20, 2008
Enzon Presents New Data on Its LNA Programs 14.4 KB
Oct 16, 2008
Enzon to Present Data at EORTC-NCI-AACR 12.3 KB
Sep 30, 2008
Enzon's New Oncaspar-IV(TM) Receives Orphan Drug Status in The EU 10.7 KB
Aug 11, 2008
Enzon Pharmaceuticals Announces Intention to Explore Strategic Alternatives for Specialty Pharmaceuticals Business 11.5 KB
Aug 06, 2008
Enzon Reports Solid Second Quarter 2008 Results 25.9 KB
Jul 31, 2008
Enzon Files for Spin-off of Biotech Business 11.8 KB
Jul 29, 2008
Enzon to Release Second Quarter 2008 Earnings on Wednesday, August 6, 2008; Conference Call and Webcast to Follow 9 KB
Jul 02, 2008
Enzon Eliminates Its Remaining 2008 Debt 9.6 KB
May 28, 2008
Jack Geltosky, Ph.D. Joins Enzon's Board of Directors 8.3 KB
May 22, 2008
Enzon Stockholders Approve Company Proposals at 2008 Annual Meeting 9.5 KB

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Current page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • …
  • Next page next ›
  • Last page last »

©2025 Enzon Pharmaceuticals, Inc., All Rights Reserved.